3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Melanoma
2
Lymphoma
2
Lung Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Cisplatin
4
Radiotherapy
3
Cetuximab
3
pembrolizumab
2
Surveys and Questionnaires
2
Carboplatin
2
olaparib
1
niraparib
1
fludarabine
1
dostarlimab
1
cemiplimab
1
calcipotriene
1
avelumab
1
atezolizumab
1
aldesleukin
1
Watchful Waiting
1
Tiragolumab
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Platinum
1
Phlebotomy
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Afatinib
×
30 days
×
Clear all
No trials found.